Skip to content

PanACEA

  • Contact us
  • Twitter
  • News
  • About Us
    • Mission
    • History
    • Governance
    • Donors
    • Scientific Network
  • Tuberculosis
    • Impact
    • Treatment
    • Drug development
  • Clinical Studies
    • Trial Design
    • PanACEA Studies
    • Vision for future Studies
  • Capacity Development

Medical and Molecular Laboratories Limited MML

Posted on May 21, 2013July 12, 2017 by admin

Medical and Molecular Laboratories Limited MML
Makerere University
P.O. Box 7062
Kampala
UGANDA

Chief Investigator: Dr Alphonse Okwera
Contact: Ms Geraldine Nalwadda
Website: www.mak.ac.ug

Posted in network-scietific, Uncategorized

Post navigation

← Kilimanjaro Clinical Research Institute (KCRI)
testing1 →

Recent Posts

  • PanACEA-SUDOCU-01 publication in the Lancet Infectious Diseases 08 July 2025
  • Podcast on TB drug development with Lilian Tina Minja and Norbert Heinrich for the Lancet
  • Dr Jodie Schildkraut
  • Dr. Laura Paramo MD
  • Staggered dosing of rifampicin using to minimise tolerability problems and maximize efficacy
© PanACEA
  • edctp
  • European Union

  • This project is part of the
    EDCTP2 programme supported
    by the European Union

  • Contact us
  • Twitter